Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
184 rows where in_cev_map = 0, surface_class = "A_assoc" and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, aptamer_count_pubmed
tier 1
- Tier 1.5 · 184 ✖
surface_class 1
- A_assoc · 184 ✖
in_cev_map 1
- - · 184 ✖
has_activation_state_pdb_pair 1
- 0 184
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q00604 | NDP | Norrin | Tier 1.5 | 0.707 | 1 | A_assoc | 11 | 83.56 | 1 | 0 | 1 | 2 | 39057719, 11352723 | 0 | Norrie disease | 0.8566451682188412 | ||
| O95970 | LGI1 | Leucine-rich glioma-inactivated protein 1 | Tier 1.5 | 0.697 | 1 | A_assoc | 9 | 92.56 | 1 | 0 | 0 | 0 | 0 | autosomal dominant epilepsy with auditory features | 0.8225657483127345 | |||
| Q13253 | NOG | Noggin | Tier 1.5 | 0.685 | 1 | A_assoc | 2 | 86.06 | 0 | 0 | 1 | 2 | 38397086 | 0 | proximal symphalangism 1A | 0.7844136456463046 | ||
| P03971 | AMH | Anti-Muellerian hormone | Tier 1.5 | 0.685 | 1 | A_assoc | 3 | 68.62 | 1 | 0 | 1 | 2 | 41101154, 27364573 | 0 | persistent Mullerian duct syndrome | 0.7847328444470535 | ||
| P01138 | NGF | Beta-nerve growth factor | Tier 1.5 | 0.684 | 1 | A_assoc | 8 | 73.25 | 0 | 0 | 1 | 6 | 42015870, 38780008, 32982626, 21216401, 7545283, 29754498 | 0 | hereditary sensory and autonomic neuropathy type 5 | 0.7785402119369383 | ||
| P18510 | IL1RN | Interleukin-1 receptor antagonist protein | Tier 1.5 | 0.682 | 1 | A_assoc | 5 | 87.06 | 0 | 0 | 1 | 1 | 38928037 | 0 | sterile multifocal osteomyelitis with periostitis and pustulosis | 0.7734282711738736 | ||
| P29120 | PCSK1 | Neuroendocrine convertase 1 | Tier 1.5 | 0.682 | 1 | A_assoc | 3 | 82.5 | 0 | 0 | 0 | 0 | 0 | obesity due to prohormone convertase I deficiency | 0.773875795833803 | |||
| P16112 | ACAN | Aggrecan core protein | Tier 1.5 | 0.677 | 1 | A_assoc | 4 | 51.91 | 0 | 0 | 0 | 0 | 0 | Familial osteochondritis dissecans | 0.7558487616449627 | |||
| P55789 | GFER | FAD-linked sulfhydryl oxidase ALR | Tier 1.5 | 0.677 | 1 | A_assoc | 7 | 76.88 | 0 | 0 | 0 | 0 | 0 | congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome | 0.7556346526616893 | |||
| Q12794 | HYAL1 | Hyaluronidase-1 | Tier 1.5 | 0.672 | 1 | A_assoc | 1 | 94.0 | 0 | 0 | 0 | 0 | 0 | Hyaluronidase deficiency | 0.7412407206736383 | |||
| Q92752 | TNR | Tenascin-R | Tier 1.5 | 0.672 | 1 | A_assoc | 2 | 78.5 | 0 | 0 | 0 | 0 | 0 | neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus | 0.7403484347367364 | |||
| O15520 | FGF10 | Fibroblast growth factor 10 | Tier 1.5 | 0.67 | 1 | A_assoc | 2 | 80.0 | 0 | 0 | 1 | 1 | 35415885 | 0 | Lacrimoauriculodentodigital syndrome | 0.7344198619465704 | ||
| O00300 | TNFRSF11B | Tumor necrosis factor receptor superfamily member 11B | Tier 1.5 | 0.666 | 1 | A_assoc | 1 | 86.5 | 0 | 0 | 1 | 1 | 15562003 | 0 | juvenile Paget disease | 0.7184894548525037 | ||
| P11686 | SFTPC | Surfactant protein C | Tier 1.5 | 0.663 | 1 | A_assoc | 3 | 70.06 | 0 | 0 | 0 | 0 | 0 | Congenital pulmonary alveolar proteinosis | 0.7110128683619542 | |||
| O43897 | TLL1 | Tier 1.5 | 0.662 | 1 | A_assoc | 1 | 80.31 | 0 | 0 | 0 | 0 | 0 | atrial heart septal defect | 0.7050140477090344 | ||||
| P19835 | CEL | Bile salt-activated lipase | Tier 1.5 | 0.658 | 1 | A_assoc | 7 | 82.56 | 0 | 0 | 1 | 2 | 39653009, 34940276 | 0 | MODY | 0.6940743944678538 | ||
| P27352 | CBLIF | Cobalamin binding intrinsic factor | Tier 1.5 | 0.655 | 1 | A_assoc | 2 | 90.5 | 0 | 0 | 0 | 0 | 0 | hereditary intrinsic factor deficiency | 0.683930100359911 | |||
| Q9Y5C1 | ANGPTL3 | Angiopoietin-related protein 3 | Tier 1.5 | 0.652 | 1 | A_assoc | 1 | 79.62 | 0 | 0 | 1 | 1 | 23770039 | 0 | familial hypobetalipoproteinemia 2 | 0.6739043862507132 | ||
| O95631 | NTN1 | Netrin-1 | Tier 1.5 | 0.648 | 1 | A_assoc | 5 | 88.5 | 1 | 0 | 0 | 0 | 0 | mirror movements 4 | 0.6611393488240481 | |||
| O76093 | FGF18 | Fibroblast growth factor 18 | Tier 1.5 | 0.631 | 1 | A_assoc | 1 | 87.56 | 0 | 0 | 1 | 1 | 35415885 | 0 | cancer | 0.6028027301556572 | ||
| P08620 | FGF4 | Fibroblast growth factor 4 | Tier 1.5 | 0.631 | 1 | A_assoc | 1 | 81.5 | 0 | 0 | 1 | 3 | 35415885, 33536494, 7547864 | 0 | cancer | 0.6026669167438079 | ||
| Q15818 | NPTX1 | Neuronal pentraxin-1 | Tier 1.5 | 0.628 | 1 | A_assoc | 1 | 75.75 | 0 | 0 | 0 | 0 | 0 | spinocerebellar ataxia 50 | 0.5937598292127286 | |||
| P07098 | LIPF | Gastric triacylglycerol lipase | Tier 1.5 | 0.626 | 1 | A_assoc | 1 | 89.75 | 0 | 0 | 0 | 0 | 0 | obesity | 0.5864662753480862 | |||
| Q6IBW4 | NCAPH2 | Condensin-2 complex subunit H2 | Tier 1.5 | 0.62 | 1 | A_assoc | 1 | 62.41 | 1 | 0 | 0 | 0 | 0 | cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 | 0.5674645203025676 | |||
| Q9GZX6 | IL22 | Interleukin-22 | Tier 1.5 | 0.619 | 1 | A_assoc | 6 | 88.12 | 0 | 0 | 1 | 7 | 34208021, 33869115, 28942363, 26792955, 37041650 | 0 | atopic eczema | 0.5627493881195745 | ||
| Q15726 | KISS1 | Metastasis-suppressor KiSS-1 | Tier 1.5 | 0.618 | 1 | A_assoc | 2 | 59.41 | 1 | 0 | 1 | 1 | 35026192 | 0 | hypogonadotropic hypogonadism | 0.5608645918536114 | ||
| O00175 | CCL24 | C-C motif chemokine 24 | Tier 1.5 | 0.613 | 1 | A_assoc | 2 | 82.12 | 0 | 0 | 0 | 0 | 0 | Iron deficiency anemia | 0.5428194908352497 | |||
| P22466 | GAL | Galanin peptides | Tier 1.5 | 0.613 | 1 | A_assoc | 10 | 66.56 | 1 | 0 | 1 | 27 | 40382399, 40371468, 39772541, 39705316, 39681229, 39430968, 39329806, 39263318, 38487245, 38314707, 37737989, 37610431, 37512948, 36795559, 36194889, 34944985, 34635237, 33769582, 33006019, 32502344, 31778957, 31173420, 30650243, 29808997, 25940316, 21850727, 9546673 | 0 | temporal lobe epilepsy | 0.5442263564708273 | ||
| P56703 | WNT3 | Proto-oncogene Wnt-3 | Tier 1.5 | 0.608 | 1 | A_assoc | 1 | 88.25 | 0 | 0 | 1 | 2 | 40168709, 18673242 | 0 | neurodegenerative disease | 0.5272184953415704 | ||
| Q9ULL8 | SHROOM4 | Protein Shroom4 | Tier 1.5 | 0.593 | 1 | A_assoc | 1 | 47.09 | 0 | 0 | 0 | 0 | 0 | X-linked intellectual disability, Stocco dos Santos type | 0.4759334640315342 | |||
| P24855 | DNASE1 | Deoxyribonuclease-1 | Tier 1.5 | 0.591 | 1 | A_assoc | 1 | 94.25 | 0 | 0 | 1 | 1 | 36838023 | 0 | systemic lupus erythematosus | 0.4692224712894944 | ||
| P28039 | AOAH | Acyloxyacyl hydrolase | Tier 1.5 | 0.585 | 1 | A_assoc | 2 | 90.38 | 0 | 0 | 0 | 0 | 0 | type 2 diabetes mellitus | 0.4486206035972812 | |||
| P41271 | NBL1 | Neuroblastoma suppressor of tumorigenicity 1 | Tier 1.5 | 0.585 | 1 | A_assoc | 2 | 75.75 | 0 | 0 | 1 | 2 | 35026285, 29281176 | 0 | nontoxic goiter | 0.44859094265791405 | ||
| P18075 | BMP7 | Bone morphogenetic protein 7 | Tier 1.5 | 0.583 | 1 | A_assoc | 4 | 76.19 | 0 | 0 | 1 | 1 | 30537181 | 0 | Inguinal hernia | 0.4420059023371716 | ||
| P11684 | SCGB1A1 | Uteroglobin | Tier 1.5 | 0.581 | 1 | A_assoc | 2 | 88.56 | 0 | 0 | 0 | 0 | 0 | chronic obstructive pulmonary disease | 0.43588476688573263 | |||
| Q63HQ2 | EGFLAM | Pikachurin | Tier 1.5 | 0.574 | 1 | A_assoc | 3 | 80.56 | 1 | 0 | 0 | 0 | 0 | mathematical ability | 0.41387833248094535 | |||
| Q8NEV9 | IL27 | Interleukin-27 subunit alpha | Tier 1.5 | 0.573 | 1 | A_assoc | 4 | 75.62 | 1 | 0 | 1 | 2 | 35859339, 32784904 | 0 | Crohn's disease | 0.40963715551754365 | ||
| Q13007 | IL24 | Interleukin-24 | Tier 1.5 | 0.572 | 1 | A_assoc | 2 | 83.38 | 0 | 0 | 0 | 0 | 0 | clear cell renal carcinoma | 0.4074364261926763 | |||
| Q96A83 | COL26A1 | Collagen alpha-1(XXVI) chain | Tier 1.5 | 0.568 | 1 | A_assoc | 6 | 59.66 | 0 | 0 | 0 | 0 | 0 | Inguinal hernia | 0.39338285604421097 | |||
| Q9UNH6 | SNX7 | Sorting nexin-7 | Tier 1.5 | 0.567 | 1 | A_assoc | 1 | 85.81 | 0 | 0 | 0 | 0 | 0 | mathematical ability | 0.3890274527063968 | |||
| O95750 | FGF19 | Fibroblast growth factor 19 | Tier 1.5 | 0.566 | 1 | A_assoc | 4 | 79.81 | 0 | 0 | 1 | 4 | 35415885, 31967847, 27679852 | 0 | cancer | 0.38540691230511315 | ||
| P20783 | NTF3 | Neurotrophin-3 | Tier 1.5 | 0.565 | 1 | A_assoc | 5 | 73.75 | 0 | 0 | 0 | 0 | 0 | cancer | 0.3844129381329447 | |||
| P32881 | IFNA8 | Interferon alpha-8 | Tier 1.5 | 0.563 | 1 | A_assoc | 1 | 84.62 | 0 | 0 | 0 | 0 | 0 | renal cell carcinoma | 0.375708720608223 | |||
| Q9UM21 | MGAT4A | Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A | Tier 1.5 | 0.561 | 1 | A_assoc | 1 | 85.25 | 0 | 0 | 0 | 0 | 0 | COVID-19 | 0.37050380432141355 | |||
| Q16674 | MIA | Melanoma-derived growth regulatory protein | Tier 1.5 | 0.559 | 1 | A_assoc | 4 | 86.38 | 0 | 0 | 1 | 15 | 41768714, 40943389, 40444021, 38899488, 37853818, 35842727, 35593028, 35061691, 34038704, 32957732, 31878307, 31289496, 29499935, 28059418, 26840019 | 0 | neurodegenerative disease | 0.36367051545295126 | ||
| Q8NBI3 | DRAXIN | Draxin | Tier 1.5 | 0.558 | 1 | A_assoc | 1 | 58.47 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.3590692945691625 | |||
| P09466 | PAEP | Glycodelin | Tier 1.5 | 0.552 | 1 | A_assoc | 1 | 86.75 | 0 | 0 | 0 | 0 | 0 | Kleefstra syndrome 1 | 0.3400134663099256 | |||
| P01282 | VIP | VIP peptides | Tier 1.5 | 0.55 | 1 | A_assoc | 5 | 67.62 | 1 | 0 | 1 | 24 | 41292425, 40957130, 40403614, 40056883, 39952883, 38763821, 37527574, 36669289, 36129574, 35879297, 35436736, 33990848, 33688885, 31689596, 31403149, 30167802, 30069577, 29708252, 28441340, 27542489, 27334718, 27088368, 26802746, 25782595 | 0 | uterine fibroid | 0.3332844575068197 | ||
| O95711 | LY86 | Lymphocyte antigen 86 | Tier 1.5 | 0.548 | 1 | A_assoc | 1 | 87.06 | 0 | 0 | 1 | 1 | 40396427 | 0 | intestinal infectious disease | 0.3265929422261205 | ||
| P14316 | IRF2 | Interferon regulatory factor 2 | Tier 1.5 | 0.546 | 1 | A_assoc | 1 | 63.94 | 0 | 0 | 0 | 0 | 0 | Abnormality of the skeletal system | 0.3207414319892803 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;